Literature DB >> 3090453

Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists.

G Weinheimer, H Osswald.   

Abstract

By using the calmodulin antagonists, calmidazolium and N-(6-aminohexyl)-5-chloro-1-naphthalene-sulfonamide (W-7), the hypothesis was investigated as to whether calmodulin is involved in the sequence of events leading to the endothelium-dependent vascular smooth muscle relaxation. Endothelium-dependent relaxations were studied on two different preparations, the rabbit aorta and the pulmonary artery of the guinea pig. Relaxations were produced in the precontracted rings (noradrenaline 3 X 10(-6) mol/l) in response to acetylcholine, 10(-8) to 10(-6) mol/l (aorta), histamine, 3 X 10(-8) to 1 X 10(-6) mol/l (pulmonary artery) or the calcium ionophore A 23187, 1 X 10(-8) to 3 X 10(-7) mol/l (aorta and pulmonary artery). In the presence of calmidazolium and W-7 the endothelium-dependent relaxation was inhibited in a dose dependent manner. This inhibition was seen in a concentration range that coincides with calmodulin inhibition. The half maximal concentrations of calmidazolium for the inhibition of the relaxation of the aorta induced by acetylcholine and A 23187 were 3 X 10(-6) mol/l and 1.4 X 10(-6) mol/l and that of W-7 were 3.1 X 10(-5) and 3.6 X 10(-5) mol/l, respectively. Complete inhibition was obtained both for acetylcholine-and for A 23187-induced relaxations by preincubation with 1 X 10(-5) mol/l calmidazolium or 1 X 10(-4) mol/l W-7. The half maximal concentrations of calmidazolium for the inhibition of the relaxation of the pulmonary artery in response to histamine and A 23187 were 2.7 X 10(-6) mol/l and 3 X 10(-6) mol/l and complete inhibition was achieved at 1 X 10(-5) mol/l.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090453     DOI: 10.1007/bf00500093

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Calmodulin stimulates human platelet phospholipase A2.

Authors:  P Y Wong; W Y Cheung
Journal:  Biochem Biophys Res Commun       Date:  1979-09-27       Impact factor: 3.575

Review 2.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.

Authors:  R M Rapoport; F Murad
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1983

3.  The calmodulin fraction responsible for contraction in an intestinal smooth muscle.

Authors:  J C Rüegg; G Pfitzer; M Zimmer; F Hofmann
Journal:  FEBS Lett       Date:  1984-05-21       Impact factor: 4.124

Review 4.  Role of endothelium in responses of vascular smooth muscle.

Authors:  R F Furchgott
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

5.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

6.  Calcium, calmodulin, and the production of prostacyclin by cultured vascular endothelial cells.

Authors:  J M Seid; S MacNeil; S Tomlinson
Journal:  Biosci Rep       Date:  1983-11       Impact factor: 3.840

7.  Calmodulin: an overview.

Authors:  W Y Cheung
Journal:  Fed Proc       Date:  1982-05

8.  Histamine release induced from rat mast cells by the ionophore A23187 in the absence of extracellular calcium.

Authors:  T Johansen
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

9.  Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta.

Authors:  H A Singer; M J Peach
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

10.  Calmodulin, Ca2+-antagonists and Ca2+-transporters in nerve and muscle.

Authors:  J D Johnson; L A Wittenauer; R D Nathan
Journal:  J Neural Transm Suppl       Date:  1983
View more
  8 in total

1.  Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery.

Authors:  S Illiano; T Nagao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

Review 2.  Endothelium-derived relaxing factor and the pulmonary circulation.

Authors:  G Cremona; A T Dinh Xuan; T W Higenbottam
Journal:  Lung       Date:  1991       Impact factor: 2.584

3.  Fendiline and calmidazolium enhance the release of endothelium-derived relaxant factor and of prostacyclin from cultured endothelial cells.

Authors:  R Busse; A Lückhoff; I Winter; A Mülsch; U Pohl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

4.  Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery.

Authors:  T Nagao; S Illiano; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

5.  Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

Authors:  H Moritoki; H Miyano; S Takeuchi; M Yamaguchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 6.  Putative therapeutic applications of calmodulin antagonists.

Authors:  R Mannhold; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

7.  Pertussis toxin and N-ethylmaleimide inhibit histamine- but not calcium ionophore-induced endothelium-dependent relaxation.

Authors:  G Weinheimer; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

8.  Relaxation of rat thoracic aorta induced by the Ca(2+)-ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation.

Authors:  H Moritoki; T Hisayama; S Takeuchi; W Kondoh; M Imagawa
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.